Newly Identified Genetic Markers Classify Previously Undetermined GBM Tumors
Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot be identified.
Researchers Identify Promising New Drug Target for Lethal Prostate Cancer
Targeting a protein genome-binding process that directs expression of diverse cancerous genes could be an important new therapy approach for stopping the progression of late-stage prostate cancer,
Stages of Complex Grant Development (Part 2)
In the last post, I identified five stages for successful complex grant development.
Duke’s Samad named Chairwoman of Dept. of Medicine at Aga Khan University in Pakistan
On July 1, Zainab Samad, MBBS, MHS, associate professor of Medicine at Duke, will become the first chairwoman of the Department of Medici
Small Study Suggests a New Way to Treat Fluid Buildup in Heart Failure
Duke team challenges the paradigm about fluid as a symptom of heart failure
Smell Receptor Fuels Prostate Cancer Progression
When scientists first described the receptors responsible for our sense of smell, they naturally assumed that these chemical sensors resided exclusively in the lining of our noses.
Clinical Research Day highlights the role of new technologies in building partnerships
Innovation Speaker, Tom Insel, MD